[Rectal administration of midazolam as an adjuvant in the premedication of infants].
In a randomized, double-blind study of premedication in 69 infants aged between 13 and 48 months the effects of 0.82 mg/kg midazolam or diazepam rectally plus 2.0 mg/kg ketamine i.m., or the administration of 2.4 mg/kg ketamine i.m. alone was studied. A satisfying result of 94.1% following the premedication with midazolam/ketamine, of 82.9% with diazepam/ketamine and of 81.3% with ketamine alone was observed. Premedication with midazolam/ketamine was the best one in the review of vigilance, agitation, and behaviour of defence against the mask at the beginning of anaesthesia. The amnestic action of midazolam extinguished the infants' memory of the i.m.-injection. The dose of midazolam/ketamine is suitable as an effective and positive method for premedication of infants within 20 min.
D000758:Anesthesia; D001569:Benzodiazepines / Q000008:administration & dosage / Q000627:therapeutic use*; D001784:Blood Gas Analysis; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003975:Diazepam; D004311:Double-Blind Method; D006801:Humans; D007223:Infant; D007649:Ketamine; D008874:Midazolam; D011229:Preanesthetic Medication; D011897:Random Allocation; D013488:Suppositories
D013488:Suppositories; D001569:Benzodiazepines; D007649:Ketamine; D003975:Diazepam; D008874:Midazolam
Rektale Gabe von Midazolam als Adjuvans zur Prämedikaton von Kleinkindern.